Dr. Howard Smith Oncall

Vidcast:  https://youtu.be/nbwuw_LkAmg   The much touted hydroxychloroquine or HCQ does not appear to reduce infection severity or save lives.  This according to a newly pre-published French study of 181 patients with CoVid19 pneumonia.   The data shows that 20% of HCQ-treated patients versus 22% of non-treated patients required ICU care or died with 7 days of admission. Twenty-seven percent of treated patients versus 24% of the untreated developed acute respiratory distress syndrome or ARDS.  Three percent of HCQ-treated patients versus 4% of untreated died.  Nearly 10% of HCQ-treated patients stopped the drug due to cardiac complications.   More data will be forthcoming.  Just know that HCQ appears not to be a silver bullet.   https://www.medrxiv.org/content/10.1101/2020.04.10.20060699v1.full.pdf   #covid19 #coronavirus #hydroxychloroquine